— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected.
— Revenues grew 66% to $10.6 million, vs. $8.7 million expected.
— FC2 US prescription net revenues increased 148% to $6.1 million.
— Gross profit increased 57% to $7.3 million.
— VERU shares were up 3.7% in premarket hours on Wednesday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
Key highlights from NIKE’s (NKE) Q2 2026 earnings results
NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared
